Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary- adrenal axis in post-penetrating keratoplasty patients?

Eye (Basingstoke)

Volumn 26, Issue 5, 2012, Pages 699-702

  Sandhu, S S ^a   Smith, J M ^a   Doherty, M ^a   James, A ^a   Figueiredo, F C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

adrenal insufficiency; penetrating keratoplasty; topical corticosteroids

Indexed keywords

FLUOROMETHOLONE; HYDROCORTISONE; PREDNISOLONE; RIMEXOLONE; TETRACOSACTIDE;

ADRENAL SUPPRESSION; ARTICLE; CLINICAL ARTICLE; CORNEA TRANSPLANTATION; CORRELATION ANALYSIS; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PENETRATING KERATOPLASTY; TREATMENT DURATION;

EID: 84862541675     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.12     Document Type: Article

References (15)

1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54(1): 1-15.
2. Brown P, Blundell G, Greening A, Crompton G. Hypothalamo-pituitary- adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med 1991; 85(6): 501-510.
3. Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol 2002; 3(3): 141-147. (Pubitemid 34533774)
4. Flynn MD, Beasley P, Tooke JE. Adrenal suppression with intranasal betamethasone drops. J Laryngol Otol 1992; 106(9): 827-828.
5. Abraham G, Gottschalk J, Ungemach FR. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology 2005; 146(7): 3163-3171. (Pubitemid 41002825)
6. Güven A, Gülümser O, Ozgen T. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse? J Pediatr Endocrinol Metab 2007; 20(11): 1173-1182. (Pubitemid 350285257)
7. Kröger L, Kotaniemi K, Jääskeläinen J. Topical treatment of uveitis resulting in adrenal insufficiency. Acta Paediatr 2009; 98(3): 584-585.
8. Roberts SM, Lavach JD, Macy DW, Severin GA. Effect of ophthalmic prednisolone acetate on the canine adrenal gland and hepatic function. Am J Vet Res 1984; 45(9): 1711-1714. (Pubitemid 14039203)
9. Burch P, Migeon C. Systemic absorption of topical steroids. Arch Ophthalmol 1968; 79(2): 174-176.
10. Krupin T, Mandell A, Podos M, Becker B. Topical corticosteroid therapy and pituitary-adrenal function. Arch Ophthalmol 1976; 94: 919-920.
11. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996; 44(2): 151-156. (Pubitemid 26042968)
12. Hurel SJ, Thompson CJ, Watson MJ, Harris NM, Baylis PH, Kendal-Taylor P. Audit of short synacthen and insulin stress tests in the assessment of the hypothalamopituitary-adrenal axis. Clin Endocrinol (Oxf) 1996; 44: 141-146. (Pubitemid 26042966)
13. Kane KF, Emery P, Sheppard MC, Stewart PM. Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen test versus the insulin tolerance test. QJM 1995; 88(4): 263-267.
14. Streeten DHP, Anderson GH, Bonaventyra MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotrophin test. J Clin Endocrinol Metab 1996; 81(1): 285-290. (Pubitemid 26035035)
15. Abdu TAM, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamopituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84(3): 838-843. (Pubitemid 29138205)